123 related articles for article (PubMed ID: 24326128)
1. Change in urinary N-acetyl-β-d-glucosaminidase levels relevant to postprandial glycemic control conditions in subjects without diabetes mellitus.
Ouchi M; Oba K; Ohara M; Igari Y; Futami-Suda S; Ishii K; Aoyama J; Onishi T; Tsunoda-Kubota M; Yamashita H; Suzuki T; Nakano H
Clin Chim Acta; 2014 Jun; 433():88-92. PubMed ID: 24326128
[TBL] [Abstract][Full Text] [Related]
2. Postprandial glycemic control conditions in relation to urinary N-acetyl-β-D-glucosaminidase in patients with type 2 diabetes mellitus without low glomerular filtration rate.
Ouchi M; Oba K; Motoyama M; Tsunoda M; Yamashita H; Aoyama J; Saigusa T; Ishii K; Yano H; Hashimoto M; Sekimizu K; Suzuki T; Nakano H
Diabetes Technol Ther; 2014 Jan; 16(1):41-7. PubMed ID: 24111861
[TBL] [Abstract][Full Text] [Related]
3. Urinary N-acetyl-β-D-glucosaminidase levels are positively correlated with 2-hr plasma glucose levels during oral glucose tolerance testing in prediabetes.
Ouchi M; Suzuki T; Hashimoto M; Motoyama M; Ohara M; Suzuki K; Igari Y; Watanabe K; Nakano H; Oba K
J Clin Lab Anal; 2012 Nov; 26(6):473-80. PubMed ID: 23143631
[TBL] [Abstract][Full Text] [Related]
4. Association between the Urinary N-acetyl-β-D-Glucosaminidase/Creatinine Ratio and Factors of the Metabolic Syndrome.
Lee E; Lee YK; Kang HJ
Ann Clin Lab Sci; 2018 Sep; 48(5):627-633. PubMed ID: 30373868
[TBL] [Abstract][Full Text] [Related]
5. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.
Bouvet BR; Paparella CV; Arriaga SM; Monje AL; Amarilla AM; Almará AM
Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):798-801. PubMed ID: 25465599
[TBL] [Abstract][Full Text] [Related]
7. Association between pulse wave velocity and a marker of renal tubular damage (N-acetyl-β-D-glucosaminidase) in patients without diabetes.
Ouchi M; Oba K; Saigusa T; Watanabe K; Ohara M; Matsumura N; Suzuki T; Anzai N; Tsuruoka S; Yasutake M
J Clin Hypertens (Greenwich); 2015 Apr; 17(4):290-7. PubMed ID: 25664677
[TBL] [Abstract][Full Text] [Related]
8. Urinary N-acetyl-β-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes.
Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Kim JH; Lee BW
Medicine (Baltimore); 2016 Jul; 95(27):e4114. PubMed ID: 27399115
[TBL] [Abstract][Full Text] [Related]
9. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
[TBL] [Abstract][Full Text] [Related]
10. Contribution of glycemic control to the levels of urinary N-acetyl-beta-D-glucosaminidase (NAG), total protein, beta 2-microglobulin and serum NAG in type 1 (insulin-dependent) diabetes mellitus without macroalbuminuria.
Watanabe Y; Nunoi K; Maki Y; Nakamura Y; Fujishima M
Clin Nephrol; 1987 Nov; 28(5):227-31. PubMed ID: 3322619
[TBL] [Abstract][Full Text] [Related]
11. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
[TBL] [Abstract][Full Text] [Related]
12. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
[TBL] [Abstract][Full Text] [Related]
13. Temporal changes in urinary levels of cadmium, N-acetyl-β-d-glucosaminidase and β2-microglobulin in individuals in a cadmium-contaminated area.
Kim YD; Yim DH; Eom SY; Moon SI; Park CH; Kim GB; Yu SD; Choi BS; Park JD; Kim H
Environ Toxicol Pharmacol; 2015 Jan; 39(1):35-41. PubMed ID: 25434760
[TBL] [Abstract][Full Text] [Related]
14. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
[TBL] [Abstract][Full Text] [Related]
15. Effect of age on urinary excretion of N-acetyl-beta-D-glucosaminidase.
Oba K; Hirai M; Ajiro Y; Okazaki K; Sato S; Sasai K; Suzuki T; Nakano H; Metori S
Nihon Ika Daigaku Zasshi; 1999 Feb; 66(1):33-6. PubMed ID: 10097588
[TBL] [Abstract][Full Text] [Related]
16. Urinary N-acetyl-beta-D-glucosaminidase activity in type I diabetes mellitus.
Mungan N; Yuksel B; Bakman M; Topaloglu AK; Ozer G
Indian Pediatr; 2003 May; 40(5):410-4. PubMed ID: 12768043
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up.
Yamanouchi T; Kawasaki T; Yoshimura T; Inoue T; Koshibu E; Ogata N; Funato H; Akaoka I; Miyashita H
Diabetes Care; 1998 Apr; 21(4):619-24. PubMed ID: 9571353
[TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of N-acetyl-beta-D-glucosaminidase in children with type I diabetes mellitus.
Ellis EN; Brouhard BH; Lagrone L; Travis LB
Diabetes Care; 1983; 6(3):251-5. PubMed ID: 6347577
[TBL] [Abstract][Full Text] [Related]
19. Effects of low-level arsenic exposure on urinary N-acetyl-β-D-glucosaminidase activity.
Eom SY; Lee YC; Yim DH; Lee CH; Kim YD; Choi BS; Park CH; Yu SD; Kim DS; Park JD; Kim H
Hum Exp Toxicol; 2011 Dec; 30(12):1885-91. PubMed ID: 21622483
[TBL] [Abstract][Full Text] [Related]
20. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
Gluhovschi C; Velciov S; Kaycsa A; Gluhovschi G; Petrica L; Marian R; Bozdog G; Gadalean F; Bob F; Cioca D; Vernic C
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
